Advertisement

Topics

Batu Biologics Welcomes Rancho Santa Fe Biotech Investor to Board of Directors

15:00 EST 24 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Batu Biologics Seed Round Investor John Peck Jr. to join Board of Directors Batu Biologics, an immuno-oncology company dedicated to the development of its tumor-angiogenesis targeting immune therapy, ValloVax™, announced ...

Other Sources for this Article

Batu Biologics Inc.
Dimitri Theofilopoulos, J.D.
Chief Operations Officer
Phone: 213-359-3179
Fax: 858-597-7090
dimitri.theo@batubiologics.com
www.batubiologics.com
(No Solicitations)

NEXT ARTICLE

More From BioPortfolio on "Batu Biologics Welcomes Rancho Santa Fe Biotech Investor to Board of Directors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...